REC-2282
N/A
Report date: 2026/03/10 20:00:16
NME
Base Information
Drug NameREC-2282
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[6]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThe Ohio State University
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesRecursion Pharmaceuticals IncThe Ohio State UniversityVirginia Commonwealth University +[4]
Active IndicationsN/A
Inactive Indications +[6]
Other Information
ATC CodeN/A
Related LinksWikipedia